Cognition Therapeutics, Inc. (CGTX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
9/25
Growth 2
Margin 1
Expansion 3
Platform 1
Financial 2
latest quarter score
Earnings Reports
- 9
- 7